HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) All Versions of this Article: db07-0953v1 57/2/340    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Santos, S. H. S. Articles by Santos, R. A. S. Search for Related Content PubMed PubMed Citation Articles by Santos, S. H. S. Articles by Santos, R. A. S. Social Bookmarking                What's this?

MAS DEFICIENCY IN FVB/N MICE PRODUCES MARKED CHANGES IN LIPID AND GLYCEMIC METABOLISM

¹Laboratory of Hypertension, Department of Physiology and Biophysics, Biological Sciences Institute (ICB), Federal University of Minas Gerais (UFMG), Belo Horizonte (BH), Minas Gerais (MG), Brazil
²Max-Delbrück-Center for Molecular Medicine (MDC), Berlin-Buch, Germany
³Laboratory of Nutritional Biochemistry, Department of Biochemistry, ICB, UFMG, BH, MG, Brazil
⁴Laboratory of Cellular Metabolism, Department of Physiology and Biophysics, ICB, UFMG, BH, MG, Brazil

Objective: Metabolic syndrome is characterized by the variable coexistence of obesity, hyperinsulinemia, insulin resistance, dyslipidemia, and hypertension. It is well known that angiotensin II is importantly involved in metabolic syndrome. However, the role of the vasodilator angiotensin-(1-7)/Mas axis is not known. The aim of this study was to evaluate the effect of genetic deletion of G protein-coupled receptor, Mas, in the lipidic and glycemic metabolism in FVB/N mice.

Research Design and Methods: Plasma lipids, insulin and cytokines concentrations were measured in FVB/N Mas-deficient and wild type mice. A glucose-tolerance test was performed by intraperitoneally injecting D-glucose into overnight fasted mice. Insulin sensitivity test was performed by intraperitoneal injection of insulin. Uptake of 2-deoxy-[3H]glucose by adipocytes was used to determine the rate of glucose transport; adipose tissue GLUT4 was quantified by Western blot. Gene expression of TGF-ß, AT1R and angiotensinogen were measured by real time PCR.

Results: Despite of normal body weight, Mas-knockout mice presented dyslipidemia, increased levels of insulin and leptin, and 50% increase in abdominal fat mass. In addition, Mas-gene deleted mice presented glucose intolerance and reduced insulin sensitivity as well as a decrease in insulin-stimulated glucose uptake by adipocytes and decreased GLUT4 in adipose tissue. Mas^–/– presented increased muscle triglycerides while liver triglycerides level was normal. Expression of TGF-ß and angiotensinogen genes was higher in Mas-knockout animals in comparison to controls.

Conclusions: These results show that Mas-deficiency in FVB/N mice leads to dramatic changes in glucose and lipid metabolisms, inducing a metabolic syndrome-like state.

Key Words: Receptor Mas • metabolic syndrome • renin-angiotensin-system • Glucose metabolism • dyslipidemia

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?